TL;DR
Get wellness gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Intake Breathing has received a $62 million investment from Camino Partners, its first significant outside capital, according to Athletech News. The family-run company says it plans to use the funding to expand beyond direct online sales into physical retail and specialty channels and to hire staff; the investment terms and rollout schedule were not reported.
Intake Breathing has received a $62 million investment from Camino Partners, the firm founded by Kind Snacks creator Daniel Lubetzky, as the magnetic nasal-dilator company prepares to expand into physical retail and specialty channels. The investment is the family-run business’s first significant outside capital, according to Athletech News.
Intake was founded by inventor and medical-device engineer Jim Castillo and is led by his son-in-law, co-founder and CEO Alex Hauck. Its product uses a reusable magnetic band and adhesive tabs to mechanically open the nasal valve, a narrow part of the nasal airway. The design differs from conventional adhesive nasal strips, though the report does not provide comparative testing or clinical findings about the products.
The company says it will use the new capital to pursue brick-and-mortar retail and specialty distribution and make key hires. Intake has built its business mainly through direct-to-consumer sales. Neither the company nor the report specified which retailers it is targeting, how many hires it expects to make, or when the expansion will begin.
Hauck described the investment as both financing and a partnership with experience in consumer-brand growth. Lubetzky, who founded Camino Partners after creating Kind Snacks, said the firm sees a chance for Intake to reach more consumers as interest in nasal breathing grows. Those comments describe the investors’ and company’s plans and expectations, not a guarantee of market demand or product outcomes.
A Retail Push for Nasal Breathing
The investment gives Intake substantial reported funding to move beyond a direct-to-consumer business and seek broader retail distribution. Physical shelves and specialty outlets could put the product in front of shoppers who do not encounter it online, while hiring may give the company added capacity for sales, operations and distribution. The report does not state how the capital will be allocated or whether the full amount has already been transferred.
The deal also reflects investor interest in consumer wellness businesses centered on sleep, recovery and exercise. Camino’s portfolio includes boutique fitness company Barry’s and nonalcoholic beer maker Athletic Brewing, according to the report. Its investment in Intake signals confidence in the category’s commercial potential, but does not establish that nasal dilators improve health, athletic performance or sleep for users. Those benefits should not be inferred from the funding announcement or endorsements by athletes.
Products Worth Considering

Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)

Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)

Oura Ring 5 Smart Ring, Gold, Size 8
As an affiliate, we earn on qualifying purchases.
From Family Venture to Funded Brand
Intake began with a device developed by Castillo, described in the report as a solution to a problem he encountered in his own garage. The business remained family-run as it grew, with Hauck serving as CEO. The reported $62 million investment marks a change in its financing as it prepares for a larger distribution effort.
The product’s stated purpose is to mechanically open the nasal valve using a magnetic band and adhesive tabs. Intake’s reported athlete following includes Los Angeles Dodgers pitcher Justin Wrobleski and Belgian soccer player Amadou Onana. Their association is presented as evidence of the company’s reach among sports figures; it is not independent evidence that the product produces specific medical or performance results.
Camino’s leaders have framed the opportunity as making nasal-breathing products more routine for consumers, drawing a comparison with the way Kind helped bring its snack products to market. That is the firm’s investment thesis. The source report does not offer independent market-size data or sales figures to verify the scale of the anticipated consumer shift.
“We’re not just gaining capital, we’re gaining a partner who knows exactly what it takes to help get us there.”
— Alex Hauck, Intake Breathing co-founder and CEO
Investment Terms and Rollout Details
The report gives the investment amount but does not describe the deal structure, Camino’s ownership stake, the company’s valuation, or whether the full $62 million has closed. It also does not identify planned retail partners, launch dates, hiring targets or geographic expansion plans.
Product performance and consumer demand remain separate questions from the financing announcement. The source provides no clinical study results, sales totals, or comparative evidence establishing how Intake’s device performs against conventional nasal strips. The company’s stated plans and the investor’s market outlook should not be read as proof of health or athletic benefits.
Retail Plans and Hiring Ahead
Intake says its next phase will focus on retail and specialty-channel expansion and key hires. The company has not announced specific stores, distribution agreements or a timetable in the report, so those details will determine how quickly the investment translates into wider availability.
Further updates from Intake or Camino may clarify the financing terms, staffing plans and rollout. Until then, the confirmed development is the reported $62 million backing and the company’s stated intention to grow distribution and its team.
Key Questions
Who invested in Intake Breathing?
Camino Partners, the investment firm founded by Daniel Lubetzky, invested in Intake Breathing, according to Athletech News.
How much funding did Intake Breathing receive?
The reported investment is $62 million. The source does not provide the deal structure, ownership stake or closing details.
What does Intake plan to do with the funding?
The company says it plans to expand into physical retail and specialty channels and make key hires. Specific retailers and hiring numbers have not been announced in the report.
How does Intake’s product work?
Intake describes its device as a reusable magnetic band with adhesive tabs that mechanically opens the nasal valve. The report does not include comparative testing or clinical evidence about its effects.
Source: rss
